1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol

C21H15F5N6O2 — CID 90445880

IUPAC1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol
SMILESOC1(C(F)(F)F)CN(c2nc(-c3cc(-c4ccon4)n(Cc4ccccc4F)n3)ncc2F)C1
InChIInChI=1S/C21H15F5N6O2/c22-13-4-2-1-3-12(13)9-32-17(15-5-6-34-30-15)7-16(29-32)18-27-8-14(23)19(28-18)31-10-20(33,11-31)21(24,25)26/h1-8,33H,9-11H2
InChIKeyIGULTRXBKCIFQW-UHFFFAOYSA-N
MW478.38 g/mol
LogP3.43
Rot. Bonds5

About 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol

1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol (PubChem CID 90445880) has the molecular formula C21H15F5N6O2 and a molecular weight of 478.38 g/mol. Its IUPAC name is 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol.

Molecular Properties

Compound Name1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol
PubChem CID90445880
Molecular FormulaC21H15F5N6O2
Molecular Weight478.38 g/mol
Exact Mass478.12
IUPAC Name1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol
SMILESOC1(C(F)(F)F)CN(c2nc(-c3cc(-c4ccon4)n(Cc4ccccc4F)n3)ncc2F)C1
InChIInChI=1S/C21H15F5N6O2/c22-13-4-2-1-3-12(13)9-32-17(15-5-6-34-30-15)7-16(29-32)18-27-8-14(23)19(28-18)31-10-20(33,11-31)21(24,25)26/h1-8,33H,9-11H2
InChIKeyIGULTRXBKCIFQW-UHFFFAOYSA-N
XLogP3.43
TPSA93.10 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms34
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500478.38
LogP ≤ 53.43
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol?
The IUPAC name of 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol (CID 90445880) is 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol.
What is the SMILES notation for 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol?
The canonical SMILES for 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol is OC1(C(F)(F)F)CN(c2nc(-c3cc(-c4ccon4)n(Cc4ccccc4F)n3)ncc2F)C1.
What is the InChIKey of 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol?
The InChIKey is IGULTRXBKCIFQW-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H15F5N6O2/c22-13-4-2-1-3-12(13)9-32-17(15-5-6-34-30-15)7-16(29-32)18-27-8-14(23)19(28-18)31-10-20(33,11-31)21(24,25)26/h1-8,33H,9-11H2.
What are the key properties of 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol?
1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol has a molecular weight of 478.38 g/mol, XLogP of 3.43, 5 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[5-fluoro-2-[1-[(2-fluorophenyl)methyl]-5-(1,2-oxazol-3-yl)pyrazol-3-yl]pyrimidin-4-yl]-3-(trifluoromethyl)azetidin-3-ol is sourced from PubChem (CID 90445880), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).